Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Prolor Biotech Climbs Most in Two Weeks on Trial Update

Prolor Biotech Inc. gained the most in two weeks after results from an extended Phase II trial of hGH-CTP human growth hormone showed a single weekly treatment may replace daily injections and was safe.

The shares jumped 3.8 percent, the most since April 22, to 20.89 shekels at the 4:30 p.m. close in Tel Aviv.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.